The approval is for the Abbreviated New Drug Application (ANDA) for Everolimus tablets for oral suspension (TFOS) of ...

In final draft guidance, NICE said an updated cost-effectiveness analysis had convinced it that Novartis' Afinitor (everolimus) daily pill in combination with exemestane (Pfizer's off-patent ...

Afinitor is another example of the value of ... Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research. The FDA has also accelerated approval of Onyx ...

Natco Pharma has received US FDA approval for its generic version of Everolimus tablets for oral suspension, indicated for ...

Natco Pharma receives FDA approval for Everolimus tablets, launching generic version of Afinitor Disperz in U.S. market.

Hyderabad: NATCO Pharma Limited, an Indian pharmaceutical company, has announced the approval of its Abbreviated New Drug ...

announced today that the Food and Drug Administration (FDA) has granted final approval of Everolimus Tablets for Oral Suspension (TFOS), 2mg, 3mg and 5mg, a generic version of AFINITOR DISPERZ ...